Phase 3 Trial of Apitegromab on Track for This Year & Managing Technological Issues With SMA

SMA News Today’s multimedia associate, Price Wooldridge, discusses Scholar Rock plans to initiate a pivotal trial of its muscle-targeted therapy in non-ambulatory spinal muscular atrophy patients in 2021. Technology is something DeAnn relies on to live independently. When it isn’t functioning properly it can be a hassle. DeAnn talks about issues she’s having with her internet and what she must do to make it work. Are you interested in learning more about spinal muscular atrophy? If so, please visit https://smanewstoday.com/